Addex Therapeutics (APE) Posts H1 Results; Raises $2.8M Post Period
Addex reported H1 2026 results: cash CHF 0.8M at June 30 and stable loss per share at CHF 0.03. Post period, it sold 52.97M shares for CHF 2.3M ($2.8M). It regained all rights to its GABAB PAM SUD program and advances a cough program.Material DetailsContext by AI AnalystThis update is early-stage a…